Resistance profile of human immunodeficiency virus to CADA, a novel HIV inhibitor that targets the cellular CD4 receptor

Kurt Vermeire; Kristel Van Laethem; Anne‐Mieke Vandamme; Thomas W. Bell; De Clercq Erik; Dominique Schols

Back

Resistance profile of human immunodeficiency virus to CADA, a novel HIV inhibitor that targets the cellular CD4 receptor

Article 2005 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2005

Blockade of SIV and HIV infection with CADA, a novel entry inhibitor that specifically targets the cellular CD4 receptor

Kurt Vermeire, Thomas W. Bell, Roger Le Grand, De Clercq Erik, Dominique Schols

Article2006

The candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, prevents HIV and SIV infection of human and simian cells

Kurt Vermeire, Thomas W. Bell, S. Anugu, N.H. Duffy, Roger Le Grand, De Clercq Erik, Dominique Schols

Article2002

CADA Inhibits Human Immunodeficiency Virus and Human Herpesvirus 7 Replication by Down-modulation of the Cellular CD4 Receptor

Kurt Vermeire, Ying Zhang, Katrien Princen, Sigrid Hatse, M Samala, K Dey, Heung‐Jin Choi, Young-Mi Ahn, A Sodoma, Robert Snoeck, Graciela Andreï, De Clercq Erik, Thomas W. Bell, Dominique Schols

Article2006

Cyclotriazadisulfonamide (CADA) compounds, HIV entry inhibitors that specifically target the cellular CD4 receptor

Dominique Schols, Kristel Van Laethem, De Clercq Erik, Thomas W. Bell, Kurt Vermeire

Article2004

A novel class of HIV inhibitors that target the cellular CD4 receptor

Kurt Vermeire, T.W. Bell, De Clercq Erik, Dominique Schols